Sarah Rudman

5.7k total citations
38 papers, 788 citations indexed

About

Sarah Rudman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Sarah Rudman has authored 38 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 11 papers in Cancer Research. Recurrent topics in Sarah Rudman's work include Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (8 papers) and Renal cell carcinoma treatment (5 papers). Sarah Rudman is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (8 papers) and Renal cell carcinoma treatment (5 papers). Sarah Rudman collaborates with scholars based in United Kingdom, Sweden and United States. Sarah Rudman's co-authors include Mieke Van Hemelrijck, Simon Chowdhury, Aspasia Soultati, Danielle Crawley, Jan Adolfsson, Alejo Rodríguez‐Vida, Cecilia Bosco, Limangeni Mankhambo, Maxwell Kanjala and Thomas Powles and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sarah Rudman

37 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Rudman United Kingdom	16	314	263	247	229	141	38	788
Joseph M Jacob United States	13	243 0.8×	344 1.3×	155 0.6×	221 1.0×	85 0.6×	99	770
A. Le Duc France	16	393 1.3×	372 1.4×	203 0.8×	210 0.9×	73 0.5×	65	1.0k
Jiwon Lim South Korea	16	168 0.5×	185 0.7×	240 1.0×	72 0.3×	69 0.5×	40	630
Connie G. Chiu Canada	14	103 0.3×	163 0.6×	304 1.2×	203 0.9×	84 0.6×	19	702
Barbara Selle Germany	16	258 0.8×	108 0.4×	181 0.7×	351 1.5×	66 0.5×	25	912
Alma van de Pol Netherlands	3	152 0.5×	233 0.9×	331 1.3×	66 0.3×	103 0.7×	5	710
Sukhbinder Dhesy‐Thind Canada	17	263 0.8×	162 0.6×	842 3.4×	156 0.7×	299 2.1×	50	1.3k
J.-J. Patard France	12	486 1.5×	245 0.9×	140 0.6×	360 1.6×	141 1.0×	52	759
Geraldine R. Vink Netherlands	17	233 0.7×	96 0.4×	405 1.6×	202 0.9×	172 1.2×	82	995
Eric K. Seaman United States	15	575 1.8×	237 0.9×	87 0.4×	142 0.6×	81 0.6×	28	926

Countries citing papers authored by Sarah Rudman

Since Specialization

Citations

This map shows the geographic impact of Sarah Rudman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Rudman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Rudman more than expected).

Fields of papers citing papers by Sarah Rudman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Rudman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Rudman. The network helps show where Sarah Rudman may publish in the future.

Co-authorship network of co-authors of Sarah Rudman

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Rudman. A scholar is included among the top collaborators of Sarah Rudman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Rudman. Sarah Rudman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cahill, Fidelma, Harriet Wylie, Cheryl Gillett, et al.. (2022). Invadopodia play a role in prostate cancer progression. BMC Cancer. 22(1). 386–386. 9 indexed citations

George, Gincy, Sarah Rudman, Zoe Moon, et al.. (2021). Qualitative Analysis of Interviews and Focus Groups Exploring Factors Contributing to Adherence to GnRH Agonists in Men with Prostate Cancer. Seminars in Oncology Nursing. 38(4). 151236–151236. 4 indexed citations

Alifrangis, Constantine, Olivia Lucas, Sarah Benafif, et al.. (2020). Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery. European Urology Focus. 7(4). 835–842. 7 indexed citations

Shamash, Jonathan, Wendy Ansell, Constantine Alifrangis, et al.. (2020). The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG). British Journal of Cancer. 124(2). 368–374. 10 indexed citations

Crawley, Danielle, Hans Garmo, Sarah Rudman, et al.. (2018). Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study. BMJ Open. 8(3). e020787–e020787. 7 indexed citations

Cook, Gary, Gurdip Azad, Benjamin Taylor, et al.. (2018). Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment. European Journal of Nuclear Medicine and Molecular Imaging. 45(6). 898–903. 10 indexed citations

Crawley, Danielle, Florence Chamberlain, Hans Garmo, et al.. (2018). A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus. ecancermedicalscience. 12. 802–802. 24 indexed citations

Kelly‐Morland, Christian, Sarah Rudman, Paul Nathan, et al.. (2017). Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study. BMC Cancer. 17(1). 392–392. 12 indexed citations

Crawley, Danielle, Ashish Chandra, Massimo Loda, et al.. (2017). Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer. BMC Cancer. 17(1). 494–494. 17 indexed citations

10.

Crawley, Danielle, Massimo Loda, Cheryl Gillett, et al.. (2016). Metformin and longevity (METAL): A window of opportunity study investigating the biological effects of metformin in localised prostate cancer. Annals of Oncology. 27. vi261–vi261. 2 indexed citations

11.

Suder, Aneta, J.E. Ang, Sarah Rudman, et al.. (2015). A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours. European Journal of Cancer. 51(16). 2275–2284. 22 indexed citations

12.

Rodríguez‐Vida, Alejo, Matilde Saggese, Simon Hughes, et al.. (2015). Complexity of FGFR signalling in metastatic urothelial cancer. Journal of Hematology & Oncology. 8(1). 119–119. 23 indexed citations

13.

Rodríguez‐Vida, Alejo, Simon Chowdhury, Cora N. Sternberg, Sarah Rudman, & Myria Galazi. (2015). Enzalutamide for the treatment of metastatic castration-resistant prostate cancer. Drug Design Development and Therapy. 9. 3325–3325. 49 indexed citations

14.

Roulstone, Victoria, Khurum Khan, Hardev Pandha, et al.. (2014). Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors. Clinical Cancer Research. 21(6). 1305–1312. 42 indexed citations

15.

Melvin, Jennifer, Hans Garmo, Rhian Daniel, et al.. (2014). An investigation into the relationship between statins and cancer using population‐based data. British Journal of Urology. 116(5). 681–683. 5 indexed citations

16.

Rodríguez‐Vida, Alejo, Diletta Bianchini, Mieke Van Hemelrijck, et al.. (2014). Is there an antiandrogen withdrawal syndrome with enzalutamide?. British Journal of Urology. 115(3). 373–380. 27 indexed citations

17.

Hemelrijck, Mieke Van, et al.. (2013). Global incidence and outcome of testicular cancer. Clinical Epidemiology. 5. 417–417. 156 indexed citations

18.

Thillai, Kiruthikah, Suzanne Allan, Thomas Powles, Sarah Rudman, & Simon Chowdhury. (2012). Neoadjuvant and adjuvant treatment of renal cell carcinoma. Expert Review of Anticancer Therapy. 12(6). 765–776. 16 indexed citations

19.

Josephs, Debra H., Sarah Rudman, Panagiotis Karagiannis, et al.. (2011). IgE immunotherapy of solid tumours: a novel model targeting folate receptor alpha (FR alpha)-positive carcinomas with MOv18 IgE. British Journal of Dermatology. 164(4). 909–910.

20.

Rudman, Sarah. (2009). Knowledge Management and the Intranet at Field Fisher Waterhouse. Legal Information Management. 9(4). 250–253. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact